For Immediate Release
 
Steven Visuri, Prodesse CSO, to Speak at 2005 International Symposium on
Respiratory Viral Infections


WAUKESHA, WI (February 2, 2005) - Prodesse, Inc. announced today that its Chief Science Officer, Steven Visuri, PhD, has accepted an invitation to speak at the VII International Symposium on Respiratory Viral Infections. Dr. Visuri’s presentation, "Real Time PCR Applications for Detection of Respiratory Pathogens", will describe commercially available products and highlight Prodesse’s multiplex ProFlu-1™ reagents. Prodesse’s ProFlu-1™, Hexaplex® and Hexaplex® Plus are the only commercially available reagents that labs have used to develop assays for multiplex detection of respiratory viruses from a single sample. The Symposium is comprised of many leaders in the respiratory virology field and is being held March 3-6 at the Curaçao Marriott Beach Resort in the Netherlands Antilles.

 

About Prodesse
Prodesse is a biotechnology company focused on developing analyte specific reagents that can be used by CLIA certified laboratories to develop assays for detecting infectious disease pathogens. The Company's reagents incorporate proprietary technology that allows for the detection of multiple pathogens. Prodesse currently offers nine different multiplex products covering 33 different organisms. The company’s products can be used on a variety of detection platforms. The Company sells its reagents to laboratories throughout the US and the world, and also operates a CLIA certified laboratory for testing services in the Midwest area. For more information about Prodesse and its products, call 888-589-6974 or go to www.prodesse.com.

 
 
Press Contact:
Andy Shrago, Chief Marketing Officer
Prodesse, Inc.
Phone: (262) 446-0700
ashrago@prodesse.com
 
 
 
Go Back